Azn stock price target

Get the latest Astrazeneca PLC (AZN) stock news and headlines to help you in your trading and investing decisions. 1y Target Est: N/A: Fair Value is the appropriate price for the shares of a AZN Stock Quote - Astrazeneca PLC Common Stock Price - Nasdaq

AZN's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low AZN | AstraZeneca PLC ADR Analyst Estimates | MarketWatch Nov 09, 2019 · AstraZeneca PLC ADR analyst estimates by MarketWatch. View AZN revenue estimates and earnings estimates, as well as analyst recommendations. AZN - Stock quote for ASTRAZENECA PLC - MSN Money View the latest AZN stock quote and chart on MSN Money. AstraZeneca's Imfinzi gets FDA nod to target small-cell lung cancer Why has AstraZeneca plc’s share price outperformed the FTSE AstraZeneca Price Target | AZN - Stock Screener, Excel ...

AZN | AstraZeneca PLC ADR Analyst Estimates & Rating – WSJ

AZN Stock Price and Chart — LSE:AZN — TradingView View live ASTRAZENECA PLC ORD SHS $0.25 chart to track its stock's price action. Find market predictions, AZN financials and market news. View live ASTRAZENECA PLC ORD SHS $0.25 chart to track its stock's price action. Find market predictions, AZN financials and market news. TradingView . EN. Target at 8301 +10% . AZN, 1W. AstraZeneca (LON:AZN) gets downgraded to Sell by UBS Group ... Apr 02, 2019 · Today, AstraZeneca (LON:AZN) stock was downgraded by UBS Group from Neutral to Sell with a price target of GBX 5,400. There are 13 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Barclays Lowers AstraZeneca (LON:AZN) Price Target to GBX ... AstraZeneca (LON:AZN) had its price target dropped by equities research analysts at Barclays from GBX 8,500 ($111.81) to GBX 8,000 ($105.24) in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock.

AstraZeneca (LON:AZN) received a GBX 6,000 ($78.93) price target from stock analysts at Goldman Sachs Group in a note issued to investors on Thursday, Borsen Zeitung reports. The firm presently has a “sell” rating on the biopharmaceutical company’s stock. Goldman Sachs Group’s price target

Goldman Sachs Group Analysts Give AstraZeneca (LON:AZN) a ... AstraZeneca (LON:AZN) received a GBX 6,000 ($78.93) price target from stock analysts at Goldman Sachs Group in a note issued to investors on Thursday, Borsen Zeitung reports. The firm presently has a “sell” rating on the biopharmaceutical company’s stock. Goldman Sachs Group’s price target AZN Stock Price & Charts | AstraZeneca In depth view into AZN (AstraZeneca) stock including the latest price, news, dividend history, earnings information and financials.

57 rows · Nov 09, 2019 · 47 Wall Street analysts have issued ratings and price targets for Amazon.com …

Jan 01, 2010 · Astrazeneca PLC (NYSE: AZN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Price Target Analysis: Astrazeneca PLC(NYSE:AZN): SELLAS ... Apr 26, 2019 · Analysts reported that the Price Target for Astrazeneca PLC might touch $58.64 high while the Average Price Target and Low price Target is $43.93 and $31.9 respectively.

13 Apr 2018 AstraZeneca and GlaxoSmithKline share price targets tweaked and on while maintaining its positive stance on the stocks of both businesses.

AstraZeneca plc (NYSE:AZN) gets downgraded to Sell by UBS ... Apr 02, 2019 · Today, AstraZeneca plc (NYSE:AZN) stock was downgraded by UBS Group from Neutral to Sell with a price target of $40.73. There are 11 Buy Ratings, 3 … AstraZeneca (LON:AZN) Given a GBX 8,500 Price Target at ... JPMorgan Chase & Co. set a GBX 8,500 ($111.81) price target on AstraZeneca (LON:AZN) in a research note released on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Other research analysts … AZN Split History AstraZeneca (AZN) has 2 splits in our AZN split history database. The first split for AZN took place on April 08, 1998. This was a 3 for 1 split, meaning for each share of AZN owned pre-split, the shareholder now owned 3 shares.

As on 2nd May 2016 AZN Share Price closed @ 0.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. Stockfuse | AZN (Astrazeneca PLC) Quotes, Sentiment ... Stock quotes, social news, market sentiment, and price targets for AZN (Astrazeneca PLC). AstraZeneca plc (NYSE:AZN) gets downgraded to Sell by UBS ... Apr 02, 2019 · Today, AstraZeneca plc (NYSE:AZN) stock was downgraded by UBS Group from Neutral to Sell with a price target of $40.73. There are 11 Buy Ratings, 3 … AstraZeneca (LON:AZN) Given a GBX 8,500 Price Target at ...